Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Ultrasonography contrast agent"
Filter
Filter
Article category
Publication year
Review Articles
Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass
Min Kyu Kang, Moon Young Kim, Seong Hee Kang, Soon Koo Baik
J Liver Cancer. 2019;19(2):91-96.   Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.91
  • 6,197 Views
  • 112 Downloads
  • 2 Citations
AbstractAbstract PDF
Contrast-enhanced ultrasonography (CEUS) using microbubble ultrasonography contrast agent can show the vascular structure and unique contrast enhancement patterns of focal liver lesions, including hepatocellular carcinoma (HCC). CEUS shows three phases, similar to a vascular pattern on computer tomography (CT), and typical arterial enhancement and portal or late phase washout in HCC. CEUS can show real-time images without nephrotoxicity or radiation hazard and can be used as guidance for loco-regional treatment and estimation of treatment response of HCC. In addition, some data recently revealed the usefulness of CEUS in the early estimation of response to anti-cancer pharmacological (i.e., sorafenib) therapy in advanced HCC. Although CEUS has limitations in clinical practice and more investigation is needed for its validation, it is recommended as a main diagnostic modality in a few major clinical practice guidelines for HCC. Thus, greater understanding of CEUS is necessary to extend its application in real practice for diagnosis and management of diseases.

Citations

Citations to this article as recorded by  
  • The value of contrast-enhance ultrasound in the diagnosis of hepatic post-transplant lymphoproliferative disease: Four case reports
    Xingqi Lu, Jingtong Yu, Litao Ruan, Kazushi Numata, Dong Zhang, Feiqian Wang
    Intractable & Rare Diseases Research.2024; 13(4): 245.     CrossRef
  • Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
    Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee
    Ultrasound in Medicine & Biology.2023; 49(10): 2256.     CrossRef
Close layer
The Usefulness of Contrast-Enhanced Ultrasonography in the Diagnosis of Hepatocellular Carcinoma
Moon Young Kim
Journal of the Korean Liver Cancer Study Group. 2014;14(1):7-13.   Published online March 31, 2014
DOI: https://doi.org/10.17998/jlc.14.1.7
  • 1,476 Views
  • 10 Downloads
AbstractAbstract PDF
Contrast enhanced ultrasonography (CEUS) using microbubble ultrasonography agent is able to show the vascular structure and enhancement patterns of lesions, so it has an worth in the diagnosis of hepatocellular carcinoma (HCC) which is a typical cancer that has a characteristic neovascularization. CEUS shows 3 phase vascular pattern like computer tomography (CT) typical arterial enhancement and portal or late wash out in HCC. CEUS can show a enhancement pattern of HCC in a real time and it has no nephrotoxicity or radiation hazard. Beyond the diagnosis, CEUS has also shown usefulness in the guidance of locoregional treatment and estimation of treatment response of HCC. In addition, recently, a few data which show a usefulness of CEUS in the early estimation of response after target therapy in the advanced HCC, also have been reported. However, CEUS has limitations in clinical practice yet and more wide investigation is needed for the validation of usefulness and wide application in clinical practice. However, CEUS also has many advantages in the field of the diagnosis and management of HCC, so in in this review, we are going to introduce CEUS and overview its clinical usefulness briefly.
Close layer

JLC : Journal of Liver Cancer
TOP